Double filtration plasmapheresis can decrease factor XIII activity

Therapeutic Apheresis and Dialysis

Volumn 11, Issue 3, 2007, Pages 165-170

  Hanafusa, Norio ^a   Kondo, Yasushi ^a   Suzuki, Makoto ^b   Nakao, Akihide ^c   Noiri, Eisei ^a   Fujita, Toshiro ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b Social Insurance Central General Hospital   (Japan)

^c Toshiba General Hospital   (Japan)

Author keywords

Double filtration plasmapheresis; Factor XIII; Normal coagulation test

Indexed keywords

ALBUMIN; AZATHIOPRINE; BETAMETHASONE; BLOOD CLOTTING FACTOR 8; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; BLOOD CLOTTING TEST; BLOOD GROUP INCOMPATIBILITY; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; EPIDERMOLYSIS BULLOSA ACQUISITA; EXTRAVASCULAR SPACE; FEMALE; HALF LIFE TIME; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; MOLECULAR WEIGHT; PEMPHIGUS VULGARIS; PLASMAPHERESIS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROTEIN FUNCTION;

ADULT; BLOOD GROUP INCOMPATIBILITY; DEMYELINATING DISEASES; EPIDERMOLYSIS BULLOSA ACQUISITA; FACTOR XIII; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; P BLOOD-GROUP SYSTEM; PEMPHIGUS; PLASMAPHERESIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34248200446     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2007.00433.x     Document Type: Article

References (21)

1. Agishi T, Kaneko I, Hasuo Y et al. Double filtration plasmapheresis. Trans Am Soc Artif Intern Organs 1980 26 : 406 11.
2. Nakaji S, Yamamoto T. Membranes for therapeutic apheresis. Ther Apher 2002 6 : 267 70.
3. Loewy AG, Veneziale C, Forman M. Purification of the factor involved in the formation of urea-insoluble fibrin. Biochim Biophys Acta 1957 26 : 670 1.
4. Muszbek L, Yee VC, Hevessy Z. Blood coagulation factor XIII: structure and function. Thromb Res 1999 94 : 271 305.
5. Loewy AG, McDonagh J, Mikkola H et al. Structure and function of factor XIII. In : Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia : Lippincott Williams & Wilkins, 2001 233 47.
6. Brummel-Ziedins K, Orfeo T, Jenny NS et al. Blood coagulation and fibrinolysis. In : Greer JP, Rodgers GM, Foerster J, Paraskevas F, Lukens JN, Glader B, eds. Wintrobe's Clinical Hematology. Philadelphia : Lippincott Williams & Wilkins, 2004 678 774.
7. Board PG, Losowsky MS, Miloszewski KJ. Factor XIII: inherited and acquired deficiency. Blood Rev 1993 7 : 229 42.
8. Tosetto A, Castaman G, Rodeghiero F. Acquired plasma factor XIII deficiencies. Haematologica 1993 78 : 5 10.
9. Egbring R, Kroniger A, Seitz R. Factor XIII deficiency: pathogenic mechanisms and clinical significance. Semin Thromb Hemost 1996 22 : 419 25.
10. Gerlach R, Raabe A, Zimmermann M, Siegemund A, Seifert V. Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol 2000 54 : 260 4 discussion 264 5.
11. Mutoh S, Teh A, Shimoji Y, Nishi N, Saitoh M, Maki M. [Studies of coagulation-fibrinolysis system and cold insoluble globulin in cases of caesarean section]. Nippon Sanka Fujinka Gakkai Zasshi 1985 37 : 2049 58.
12. Hanafusa N, Noiri E, Yamashita T et al. Successful treatment by double filtrate plasmapheresis in a pregnant woman with the rare p blood group and a history of multiple early miscarriages. Ther Apher Dial 2006 10 : 498 503.
13. Furue M, Iwata M, Yoon HI et al. Epidermolysis bullosa acquisita: clinical response to plasma exchange therapy and circulating anti-basement membrane zone antibody titer. J Am Acad Dermatol 1986 14 : 873 8.
14. Engineer L, Ahmed AR. Emerging treatment for epidermolysis bullosa acquisita. J Am Acad Dermatol 2001 44 : 818 28.
15. Agishi T, Takahashi K, Yagisawa T, Ota K. Immunoadsorption of anti-A or anti-B antibody for successful kidney transplantation between ABO incompatible pairs and its limitation. Japanese Biosynsorb Research Group. ASAIO Trans 1991 37 : M496 8.
16. Agishi T, Takahashi K, Ota K, Yagisawa T. Comparative evaluation of immunoadsorption and double filtration plasmapheresis for removal of anti-A or -B antibody in ABO-incompatible kidney transplantation. Japanese Biosynsorb Research Group. Transplant Proc 1992 24 : 557 8.
17. Ismail N, Neyra R, Hakim RM. Plasmapheresis. In : Daugirdas JT, Blake PG, Ing TS, eds. Handbook of Dialysis, 3rd edn. Philadelphia : Lippincott Williams & Wilkins, 2001 231 62.
18. Mineshima M, Eguchi K, Horibe K et al. Continuous monitoring of blood Volume in double filtration plasmapheresis. ASAIO J 1998 44 : M465 9.
19. Yamada H, Takamori K, Yaguchi H, Ogawa H. A study of the efficacy of plasmapheresis for the treatment of drug induced toxic epidermal necrolysis. Ther Apher 1998 2 : 153 6.
20. Kramer BK, Ickrath O, Keppler G, Ress KM, Risler T. Effects of membrane plasma exchange on the hemostatic system and on thyroid hormones in critically ill patients. Int J Artif Organs 1987 10 : 199 204.
21. Fear JD, Miloszewski KJ, Losowsky MS. The half life of factor XIII in the management of inherited deficiency. Thromb Haemost 1983 49 : 102 5.